Skip to main content
. 2021 Jun 22;2021:6639366. doi: 10.1155/2021/6639366

Table 5.

Positive predictive value and negative predictive value of HPD in patients with pancreatic cancer with immunotherapy according to CA199 test when the cut-off value is 167%.

Evaluation parameter CA19-9
Sensitivity 85.7%
Specificity 94.1%
Positive predictive value 6/7 (85.7%)
Negative predictive value 17/18 (94.4%)

HPD: hyperprogressive disease.